Skip to main
Prescribed Wolverine

A live status board on the BPC-157 + TB-500 (Wolverine) research blend — every tissue-repair claim graded against the literature, and the regulatory access record posted in real time.

CONTACT · 09 / REACH THE PUBLISHER

Who receives a note about the BPC-157 TB-500 guide?

Your note goes to the Prescribed Wolverine publishing desk. The site names no individual editor and provides no medical care.

What the Prescribed Wolverine publishing desk will review

The form reaches the Prescribed Wolverine publishing desk, though the site doesn't give you the name or qualifications of the editor who may read your note; if you send a source question or correction, name the claim and source so the editor can check both without making you explain the whole page again.

A clear correction can make the guide more useful to you and other readers.

The desk accepts questions about BPC-157 and TB-500, but it can't give health advice, recommend a peptide, supply a compound, or fill a prescription. No doctors or pharmacists work here. Prescribed Wolverine is the publisher you are contacting. For a health question, speak with a licensed health professional. The FDA and WADA status of BPC-157 and TB-500 page explains public rules in general terms, not legal advice.

Pointing to the exact sentence and source gives the editor enough to check your concern without guessing.

What may answer your question before you write

Your question may already have a short answer. The frequently asked questions about the blend page covers the twenty-five questions readers ask most. The references page gives every source.

The publishing desk welcomes a correction that names the exact claim and source.

It can't tell you where to get the blend, how much to use, or how to use it. Published research doesn't support a human plan, and the site doesn't provide one.

If you still want to write, name the study or sentence you mean.